Open AccessManagement and support of patients with fibrosing interstitial lung diseases
Author(s) -
Tyonn Barbera,
Lesley Davila,
Nina Patel
Publication year - 2021
Publication title -
the nurse practitioner/the nurse practitioner
Language(s) - English
Resource type - Journals
eISSN - 1538-8662
pISSN - 0361-1817
DOI - 10.1097/01.npr.0000743332.64602.aa
Subject(s) - interstitial lung disease , medicine , intensive care medicine , disease , adverse effect , lung , lung disease , pathology
Fibrosing interstitial lung diseases have a variable clinical course. Regular monitoring is important to assess disease progression and inform patient care and counseling. NPs play a key role in helping patients understand their disease and its treatment and manage the adverse reactions of pharmacologic therapies.